Insights from 2023 ESMO Annual Meeting
CNS
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "REGOMA-OS Study Analyzing Regorafenib Efficacy & Safety in Recurrent Glioblastoma Patients"
FEATURING
Giuseppe Lombardi
- 112 views
- November 17, 2023
- 1